Richard D Bagnall1,2, Jodie Ingles1,2,3, Laura Yeates1,3, Samuel F Berkovic4, Christopher Semsarian1,2,3. 1. Agnes Ginges Centre for Molecular Cardiology, Centenary Institute, Sydney, Australia. 2. Sydney Medical School, University of Sydney, Sydney, Australia. 3. Department of Cardiology, Royal Prince Alfred Hospital, Sydney, Australia. 4. Epilepsy Research Centre, Department of Medicine, University of Melbourne, Austin Health, Melbourne, Australia.
Abstract
PURPOSE: Sudden death in the young is a devastating complication of inherited heart disorders. Finding the precise cause of death is important, but it is often unresolved after postmortem investigation. The addition of postmortem genetic testing, i.e., the molecular autopsy, can identify additional causes of death. We evaluated DNA extracted from formalin-fixed paraffin-embedded postmortem tissue for exome sequencing-based molecular autopsy after sudden death in the young. METHODS: We collected clinical and postmortem information from patients with sudden death. Exome sequencing was performed on DNA extracted from fixed postmortem tissue. Variants relevant to the cause of death were sought. RESULTS: Five patients with genetically unresolved sudden death were recruited. DNA extracted from fixed postmortem tissue was degraded. Exome sequencing achieved 20-fold coverage of at least 82% of coding regions. A threefold excess of singleton variants was found in the exome sequencing data of one patient. We found a de novo SCN1A frameshift variant in a patient with sudden unexpected death in epilepsy and a LMNA nonsense variant in a patient with dilated cardiomyopathy. CONCLUSION: DNA extracted from fixed postmortem tissue is applicable to exome sequencing-based molecular autopsy. Fixed postmortem tissues are an untapped resource for exome-based studies of rare causes of sudden death.Genet Med advance online publication 23 March 2017.
PURPOSE: Sudden death in the young is a devastating complication of inherited heart disorders. Finding the precise cause of death is important, but it is often unresolved after postmortem investigation. The addition of postmortem genetic testing, i.e., the molecular autopsy, can identify additional causes of death. We evaluated DNA extracted from formalin-fixed paraffin-embedded postmortem tissue for exome sequencing-based molecular autopsy after sudden death in the young. METHODS: We collected clinical and postmortem information from patients with sudden death. Exome sequencing was performed on DNA extracted from fixed postmortem tissue. Variants relevant to the cause of death were sought. RESULTS: Five patients with genetically unresolved sudden death were recruited. DNA extracted from fixed postmortem tissue was degraded. Exome sequencing achieved 20-fold coverage of at least 82% of coding regions. A threefold excess of singleton variants was found in the exome sequencing data of one patient. We found a de novo SCN1A frameshift variant in a patient with sudden unexpected death in epilepsy and a LMNA nonsense variant in a patient with dilated cardiomyopathy. CONCLUSION: DNA extracted from fixed postmortem tissue is applicable to exome sequencing-based molecular autopsy. Fixed postmortem tissues are an untapped resource for exome-based studies of rare causes of sudden death.Genet Med advance online publication 23 March 2017.
Authors: Christina G Loporcaro; David J Tester; Joseph J Maleszewski; Teresa Kruisselbrink; Michael J Ackerman Journal: Arch Pathol Lab Med Date: 2013-12-03 Impact factor: 5.534
Authors: Matthew R G Taylor; Pamela R Fain; Gianfranco Sinagra; Misi L Robinson; Alastair D Robertson; Elisa Carniel; Andrea Di Lenarda; Teresa J Bohlmeyer; Debra A Ferguson; Gary L Brodsky; Mark M Boucek; Jean Lascor; Andrew C Moss; Wai Lun P Li; Gary L Stetler; Francesco Muntoni; Michael R Bristow; Luisa Mestroni Journal: J Am Coll Cardiol Date: 2003-03-05 Impact factor: 24.094
Authors: Sharie B Parks; Jessica D Kushner; Deirdre Nauman; Donna Burgess; Susan Ludwigsen; Amanda Peterson; Duanxiang Li; Petra Jakobs; Michael Litt; Charles B Porter; Peter S Rahko; Ray E Hershberger Journal: Am Heart J Date: 2008-03-12 Impact factor: 4.749
Authors: Michael Papadakis; Sanjay Sharma; Steve Cox; Mary N Sheppard; Vasileios F Panoulas; Elijah R Behr Journal: Europace Date: 2009-08-21 Impact factor: 5.214
Authors: J Peter van Tintelen; Robert M W Hofstra; Hilga Katerberg; Tom Rossenbacker; Ans C P Wiesfeld; Gideon J du Marchie Sarvaas; Arthur A M Wilde; Irene M van Langen; Eline A Nannenberg; Anneke J van der Kooi; Marian Kraak; Isabelle C van Gelder; Dirk Jan van Veldhuisen; Yvonne Vos; Maarten P van den Berg Journal: Am Heart J Date: 2007-09-14 Impact factor: 4.749
Authors: Berivan Baskin; Jon R Skinner; Shubhayan Sanatani; Deborah Terespolsky; Andrew D Krahn; Peter N Ray; Stephen W Scherer; Robert M Hamilton Journal: Hum Genet Date: 2013-06-29 Impact factor: 4.132
Authors: Richard D Bagnall; Douglas E Crompton; Slavé Petrovski; Lien Lam; Carina Cutmore; Sarah I Garry; Lynette G Sadleir; Leanne M Dibbens; Anita Cairns; Sara Kivity; Zaid Afawi; Brigid M Regan; Johan Duflou; Samuel F Berkovic; Ingrid E Scheffer; Christopher Semsarian Journal: Ann Neurol Date: 2016-02-02 Impact factor: 10.422
Authors: David J Tester; Daniel B Spoon; Hector H Valdivia; Jonathan C Makielski; Michael J Ackerman Journal: Mayo Clin Proc Date: 2004-11 Impact factor: 7.616
Authors: Eliezer M Van Allen; Nikhil Wagle; Petar Stojanov; Danielle L Perrin; Kristian Cibulskis; Sara Marlow; Judit Jane-Valbuena; Dennis C Friedrich; Gregory Kryukov; Scott L Carter; Aaron McKenna; Andrey Sivachenko; Mara Rosenberg; Adam Kiezun; Douglas Voet; Michael Lawrence; Lee T Lichtenstein; Jeff G Gentry; Franklin W Huang; Jennifer Fostel; Deborah Farlow; David Barbie; Leena Gandhi; Eric S Lander; Stacy W Gray; Steven Joffe; Pasi Janne; Judy Garber; Laura MacConaill; Neal Lindeman; Barrett Rollins; Philip Kantoff; Sheila A Fisher; Stacey Gabriel; Gad Getz; Levi A Garraway Journal: Nat Med Date: 2014-05-18 Impact factor: 53.440
Authors: Rafael Mena; Esperanza Mendoza; Maria Gomez Peña; C Alexander Valencia; Ehsan Ullah; Robert B Hufnagel; Carlos E Prada Journal: Am J Med Genet C Semin Med Genet Date: 2020-11-21 Impact factor: 3.359